This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Popular Anatomic Technique For ACL Reconstruction Takes Big Step Forward Thanks To New, Shorter ENDOBUTTON™ Continuous Loop Fixation Device

Stocks in this article: SN SNN

LONDON, Oct. 17, 2012 /PRNewswire/ -- Smith & Nephew (LSE: SN, NYSE: SNN), the global medical technology business, announces an exciting new product designed for the growing number of surgeons who use the anatomic technique for anterior cruciate ligament (ACL) repair. As the company's shortest ever continuous loop suture, the new ENDOBUTTON™ CL 10 mm fixation device addresses the challenges associated with the shorter femoral tunnels used in this method. While the 10 mm CL fixation device can accommodate the needs of the anatomic technique, it is also appropriate for use with other techniques for arthroscopic "keyhole" repair of the knee, including the traditional transtibial approach.  

"As an ACL surgeon, my primary goal is to restore my patients' anatomy as closely as possible to normal," explains Dr. David C. Flanigan, Associate Professor, Department of Orthopaedics, Ohio State University. "Using an anatomic approach allows me to do that. And with this new 10 mm device, I know I will get incredibly strong fixation while optimizing the amount of soft tissue graft in even the shortest of tunnels."

The ENDOBUTTON CL Ultra family is pre-threaded with the company's proprietary continuous loop of suture, making it one of the strongest soft tissue femoral fixation devices on the market today.[1],[2] In addition to adding strength, this type of continuous loop won't stretch like other suture constructs can. In fact, in lab testing the ENDOBUTTON CL Ultra Device showed 90% less displacement than a leading competitor when both were placed under load.[3]

Supported by more than 10 years of clinical experience and more than 20 peer-reviewed journals, the entire ENDOBUTTON family features Smith and Nephew's unique "flipping" characteristic that provides surgeons with tactile feedback to ensure proper seating.

"Smith and Nephew was the first company to provide surgeons with a complete range of products and techniques specifically designed to simplify anatomic ACL reconstruction," says Romeo Catracchia, Vice President, Joint Repair for Smith & Nephew. "Our ENDOBUTTON family of fixation devices, along with our new ACUFEX™ PINPOINT Anatomic ACL Guide System, CLANCY™ Anatomic Cruciate Guide, FAST-FIX™ 360 Meniscal Repair System and BIOSURE™ Interference Screws present surgeons with complete options for performing a wide variety of  anatomic ACL reconstructions."

As one of the primary support structures for the knee, the ACL is made up of functional fibre bundles that prevent excessive left/right, front/back and rotational movement of the joint. While traditional transtibial ACL repair is able to replicate some of the ligament functions, the anatomic technique attempts to more closely reproduce the overall function of the knee. For this reason, many surgeons feel that the anatomic technique is superior and may help to reduce further injury and degeneration of the patient's knee.  According to industry estimates, approximately 1 million ACL procedures are performed globally each year.

1 of 2

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 18,030.21 +6.04 0.03%
S&P 500 2,081.88 -0.29 -0.01%
NASDAQ 4,773.4720 +8.0480 0.17%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs